Disruption in Healthcare Is Here: Are You Ready? - White Paper

Engineering simulation, or the use of computer models to assess the behavior of a device or treatment in its working environment, is now used by 85 percent of the top 50 healthcare companies as part of their product and process development.

Simulating the performance of drugs, devices and therapies in a low-risk, cost-effective virtual environment can develop (disruptive) innovations much faster and at lower cost. Healthcare pioneers have repeatedly reported returns on investment of greater than 500 percent.

ANSYS is fully embracing the in silico approach by creating the necessary software and enabling access to computational power to make simulation pervasive from startups to large global companies, from concept to in-patient performance.
I want to receive updates and other offers from ANSYS and its partners. I can unsubscribe at any time. ANSYS Privacy Notice